The rapid rise of GLP-1 weight-loss drugs has come with a raucous side show—a wave of copycat drugs unbound by drug patents.

Taking a GLP-1 receptor agonist prior to bariatric surgery may not boost long-term weight loss and metabolic benefits, a ...

Many Marylanders struggle with obesity but cannot get access to weight loss medications because insurance will not pay for ...

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

Mass General Brigham researchers found that total weight loss did not increase for patients who took semaglutide before ...

Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...

Administration of semaglutide before metabolic and bariatric surgery does not confer benefits for overall weight loss, ...

Mass General Brigham researchers found that total weight loss did not increase for patients who took semaglutide before having weight loss surgery ...

Mass General Brigham researchers found that total weight loss did not increase for patients who took semaglutide before ...

Novo Nordisk (NVO) plans to study how its GLP-1 drugs marketed as Wegovy and Ozempic for obesity and diabetes can help tackle ...

RAs are transforming obesity treatment, demonstrating substantial weight loss and metabolic improvements with lifestyle ...